Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong · Delayed Price · Currency is HKD 2.790
0.00 (0.00%)
At close: Feb 13, 2026
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 1.38 billion as of February 13, 2026. Its market cap has increased by 253.36% in one year.
Market Cap
1.38B
Enterprise Value
1.41B
Revenue
12.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.79
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 1.38B, a decrease of -82.66%. That is a compound annual growth rate of -26.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.38B | 42.35% |
| Dec 31, 2025 | 967.31M | 130.32% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhaoke Ophthalmology | 1.90B |
| Cutia Therapeutics | 1.83B |
| Immunotech Biopharm | 1.59B |
| HighTide Therapeutics | 1.47B |
| CANbridge Pharmaceuticals | 1.47B |
| Wuhan YZY Biopharma | 1.40B |
| Beijing Biostar Pharmaceuticals | 1.35B |
| Shanghai Bio-heart Biological Technology | 1.31B |